Search
Close this search box.

Developing a Potency Assay for GeneRide Products: an AAV-based Genome Editing

Organization:
United States Pharmacopeial Convention
Department:
NIIMBL Funded:
No
Type:
Professional Development / Training
Relevant Technologies:
Analytical Methods / Technologies
Delivery Modalities:
Online/E-Learning
Type of Enterprise:
Tier 1/Tier 2
Contact:
education@usp.org
Location:
Middle Atlantic
Duration:
0-1 Week
Description:
The GeneRide platform utilizes the natural process of homologous recombination to achieve targeted genome editing without the use of exogenous nucleases or promoters. Developing a potency assay for this unique technology poses additional challenges…

Join Our Mailing List

MailChimp NIIMBL Mailing List Signup
Organization Type
How did you first hear about NIIMBL?